Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (66)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Portal circulation: An anatomical map
- Extrahepatic obstruction: Etiologic overview
- Thrombophilic genotype and cirrhosis
- Extrahepatic causes: Interpret by mechanism
- Known associations do not establish causation
- Contrasting small-branch phenotypes
- Hepatic artery compromise is a different lesion
- Source references and scope
Slide index & full transcript (66 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Portal Vein Obstruction
and Thrombosis
Mechanisms, anatomical levels and clinicopathologic consequences
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Localize portal venous obstruction to extrahepatic, intrahepatic radicle or small-branch compartments.
Link infectious, prothrombotic, traumatic, inflammatory and neoplastic causes to obstruction.
Explain why portal obstruction presents with abdominal pain, varices, splenomegaly or bleeding.
Distinguish large-vessel thrombosis from noncirrhotic small-portal-branch disease.
Slide 3 · Portal circulation: An anatomical map
Intestinal venous
Return
Splenic venous
Return
Portal vein
(trunk)
Intrahepatic
Portal radicles
Sinusoids
Two splanchnic drainage beds converge into portal inflow
Slide 4 · Classifying hepatic blood-flow disturbance
Compartment
Principal disturbance
Robbins example
Inflow to liver
Portal-vein occlusion
Portal vein thrombosis
Through liver
Sinusoidal or parenchymal resistance
Cirrhosis; sinusoidal occlusion
Outflow from liver
Hepatic venous drainage blocked
Hepatic vein thrombosis
Slide 5 · Portal obstruction: What is blocked?
Portal vein or tributary
Restricted venous inflow
Upstream splanchnic congestion
Portal hypertensive consequences
The location of the obstructed segment determines the distribution of pressure and clinical signs.
Slide 6 · The three anatomical levels
Extrahepatic portal vein
Occlusion before major intrahepatic branching; Diverse local/systemic triggers.
Intrahepatic portal radicles
Often acute thrombosis in malignancy or a hypercoagulable state.
Small portal branches
May cause noncirrhotic portal hypertension through microvascular obliteration.
Slide 7 · Presentation ranges from silent to catastrophic
Insidious / subclinical
May emerge clinically years later.
Symptomatic portal hypertension
Abdominal pain, varices and other congestion signs.
Severe acute event
Potentially lethal obstruction in selected cases.
Slide 8 · Why portal hypertension develops
Resistance in portal venous pathway
Pressure rises upstream
Portosystemic collaterals enlarge
Varices and congestive findings
Flow resistance, not necessarily hepatocyte failure, can dominate the presentation.
Slide 9 · Esophageal varices: A hemodynamic consequence
Portal hypertension
Collateral channels at portal–systemic junctions
Dilated distal esophageal veins
Risk of variceal rupture
A vascular pressure problem can present as upper gastrointestinal hemorrhage.
Slide 10 · Clinical expression follows vascular anatomy
Finding
Vascular interpretation
Esophageal varices
Collateral response to elevated portal pressure
Splenomegaly
Congestive change in the portal drainage bed
Intestinal congestion
Impaired splanchnic venous drainage
Ascites
Possible manifestation of portal hypertension; setting-dependent
Slide 11 · Extrahepatic portal-vein obstruction
Involves the portal trunk before its major branches enter the liver.
Etiologies include unexplained disease, infection, thrombophilia, injury and tumor involvement.
Portal-hypertensive manifestations may be more conspicuous than primary hepatocyte injury.
A long delay between precipitating event and clinical presentation is possible.
Slide 12 · Extrahepatic obstruction: Etiologic overview
Unexplained
Idiopathic
Infectious
Neonatal umbilical sepsis; Abdominal infection
Prothrombotic
Inherited/acquired states; Myeloproliferative neoplasms
Local vascular injury
Trauma; Surgery; Pancreatitis
Neoplastic / hepatic
Pancreatic cancer; HCC invasion; Cirrhosis
Slide 13 · Idiopathic obstruction is a clinical category
Approximately one-third of extrahepatic cases as idiopathic.
“Idiopathic” denotes no established cause after evaluation; It is not a unique thrombotic mechanism.
The category should be distinguished from the separate small-branch syndrome of idiopathic noncirrhotic portal hypertension.
Slide 14 · Neonatal umbilical infection and catheterization
Umbilical sepsis or venous catheter
Early portal-vein occlusion
Subclinical interval
Later variceal bleeding ± ascites
Temporal separation does not exclude a perinatal vascular origin.
Slide 15 · Why childhood history matters years later
Early event
Umbilical sepsis or umbilical venous instrumentation.
Silent interval
An occlusion may remain clinically inapparent.
Late presentation
Manifestations of portal hypertension draw attention to past vascular damage.
Slide 16 · Intra-abdominal infection as a thrombotic trigger
Acute diverticulitis and appendicitis are textbook examples.
Inflammation or infection in the abdominal venous drainage bed can extend to portal tributaries.
The resulting septic thrombophlebitic process is termed pylephlebitis.
Think of the portal vein as part of the venous drainage pathway of the infected organ.
Slide 17 · Pylephlebitis: Pathogenesis in sequence
Appendiceal / colonic infection
Septic splanchnic venous inflammation
Portal system thrombophlebitis
Obstructed portal drainage
Original mechanism schematic; No specimen or imaging is implied.
Slide 18 · Hypercoagulability may be inherited or acquired
Inherited predisposition
A thrombophilic genotype such as factor V Leiden, especially in cirrhosis-associated thrombosis.
Acquired predisposition
Myeloproliferative neoplasms, malignancy and other systemic prothrombotic conditions predispose to thrombosis.
Slide 19 · Myeloproliferative neoplasms are important
Myeloproliferative neoplasms are explicitly listed among causes of portal vein thrombosis.
Polycythemia vera is the textbook example.
Associated platelet abnormalities predispose to venous thrombosis in this unusual vascular bed.
A portal venous thrombus may be a clue to a systemic hematologic disorder.
Slide 20 · Polycythemia vera: Local consequence of systemic disease
Myeloproliferative neoplasm
Abnormal platelet-related thrombosis risk
Portal venous thrombosis
Portal-hypertensive morbidity
Textbook links the hematologic disorder to portal vascular occlusion.
Slide 21 · Thrombophilic genotype and cirrhosis
Cirrhosis is a common setting in which portal-vein thrombosis is encountered.
Thrombophilic genotypes in many affected cirrhotic patients.
Factor V Leiden is supplied as an example of inherited predisposition.
The coexistence of liver disease and thrombophilia complicates simple single-cause attribution.
Slide 22 · Trauma and surgery can precipitate thrombosis
Direct or operative injury
The textbook groups trauma, including surgical trauma, among extrahepatic causes.
Downstream result
Local vessel injury provides a plausible context for portal-venous occlusion; Investigate the temporal association.
Slide 23 · Pancreatitis links local inflammation to venous thrombosis
Pancreatitis
Splenic venous thrombosis
Extension along venous continuity
Portal vein thrombosis
Propagation from the splenic vein into the portal vein is directly identified in the source.
Slide 24 · Pancreatic cancer: An adjacent vascular risk
Pancreatic cancer is listed with splenic-vein thrombosis as a cause of portal obstruction.
The splenic and portal venous systems are anatomically continuous.
Clot propagation can convert a tributary problem into main portal-vein obstruction.
Vascular level is essential to interpret the eventual distribution of portal hypertension.
Slide 25 · Clot propagation: Tributary to portal trunk
Splenic vein involved
Thrombosis propagates
Portal trunk becomes involved
Larger drainage territory affected
This is an anatomical progression rather than a measured temporal rate.
Slide 26 · Hepatocellular carcinoma can invade the portal vein
Direct invasion of the portal venous lumen by hepatocellular carcinoma is a named cause.
The mechanism is malignant vascular involvement, not simply an unrelated coagulation disorder.
In a liver mass with portal obstruction, the possibility of tumor invasion has pathologic significance.
Slide 27 · Two mechanisms: Thrombotic occlusion or invasion
Mechanism
Robbins context
Key distinction
Thrombosis
Prothrombotic states; local inflammatory injury
Occlusion by thrombus
Tumor invasion
Hepatocellular carcinoma
Malignant involvement of portal vein
Propagation
Splenic vein thrombosis
Extension from contiguous tributary
Slide 28 · Cirrhosis is a major association
Portal-vein thrombosis in about 25% of patients with cirrhosis.
This figure is a Robbins textbook statement, not a newly estimated incidence or universal risk.
Portal hypertension can coexist with occlusive thrombus and with intrinsic cirrhotic resistance.
Do not assume all portal hypertension in cirrhosis is caused by portal-vein thrombosis.
Slide 29 · Cirrhosis: Two contributors to impaired flow
Intrahepatic resistance
Architectural scarring, nodules and vascular tone impede intrahepatic sinusoidal flow.
Superimposed portal occlusion
Portal-vein thrombosis adds upstream obstruction and may intensify portal hypertensive effects.
Slide 30 · Extrahepatic causes: Interpret by mechanism
Mechanistic family
Examples supplied by Robbins
Septic venous injury
Umbilical sepsis; appendicitis; diverticulitis
Systemic coagulation tendency
Myeloproliferative neoplasm; inherited thrombophilia
Local trauma / inflammation
Surgery; trauma; pancreatitis
Malignancy / liver disease
Pancreatic cancer; HCC; cirrhosis
Slide 31 · Intrahepatic portal radicle obstruction
The affected vessels are portal radicles after entry into the liver.
Acute thrombosis is the mechanism emphasized by Robbins.
Malignancy and other hypercoagulable states frequently provide the clinical context.
Distinguish radicle occlusion from the small-branch disorders discussed next.
Slide 32 · Why level matters: Radicles versus trunk
Portal trunk (extrahepatic)
The extrahepatic form has a wide etiologic differential including local infection, trauma, propagation and tumor.
Portal radicles (intrahepatic)
The source emphasizes acute thrombotic occlusion, commonly in a malignant or hypercoagulable setting.
Slide 33 · Malignancy and radicle thrombosis
Malignancy / prothrombotic context
Acute portal-radicle clot
Segmental inflow impairment
Clinical consequences depend on extent
The source specifies the association, not a fixed clinical phenotype for every radicle thrombus.
Slide 34 · Small portal branches: A distinct compartment
Obstruction of the smallest portal branches may produce portal hypertension without cirrhosis.
The pathogenic processes are not all the same.
Schistosomiasis is identified as the most common cause of small-branch obstruction.
Other disorders are grouped by the textbook under idiopathic noncirrhotic portal hypertension.
Slide 35 · Schistosomiasis: The obstructing lesion
Schistosome eggs in portal microvasculature
Granulomatous inflammation
Small portal branch obstruction
Noncirrhotic portal hypertension
Microvascular obstruction is driven by eggs and the host granulomatous response.
Slide 36 · Why granulomas matter in schistosomiasis
Deposited material
Parasite eggs lodge in the small portal venous branches.
Host response
Granulomatous inflammation compounds mechanical obstruction and alters the microvascular lumen.
Slide 37 · Small-branch disease is not synonymous with cirrhosis
Feature
Small portal branch obstruction
Cirrhosis
Main lesion emphasized
Portal microvascular obstruction
Diffuse architectural distortion
Portal hypertension
Can occur without cirrhosis
Common dominant consequence
Examples
Schistosomiasis; idiopathic noncirrhotic PH
Multiple chronic hepatic injuries
Slide 38 · Idiopathic noncirrhotic portal hypertension
A collective label for disorders involving obstruction of small portal vein branches.
Underlying pathogenetic processes are not completely established.
Associations span coagulation, infection, immunity, toxic exposure and biliary disease.
Clinical manifestations may arise despite absence of established cirrhosis.
Slide 39 · Known associations do not establish causation
The pathogenesis is unknown.
A documented association with HIV, drugs or autoimmune disease is not proof of a single mechanism.
The category is heterogeneous; A unifying explanation should not be assumed.
Use qualifying language when teaching proposed etiologic relationships.
Slide 40 · The association map in small-branch disease
Coagulation
Prothrombotic states
Infection
HIV and other infections
Exposure
Drugs; Toxins
Immune
Immune deficiency; Autoimmune disease
Biliary
Chronic biliary obstruction
Slide 41 · Immune, infectious and biliary associations
Association
Source wording
Interpretation
HIV infection
Observed in untreated infection
An association; mechanism unresolved
Autoimmune disorders
Reported among associated conditions
Does not imply universal causality
Chronic biliary obstruction
Linked to small-branch syndrome
May coexist with portal hypertensive manifestations
Slide 42 · Drugs and toxins: An attribution limitation
Drugs and toxins are recorded as associations with idiopathic noncirrhotic portal hypertension.
The excerpt does not name a causative substance or dose.
It also does not provide a mechanism-specific histologic criterion.
Avoid presenting an unlisted drug, toxicity threshold or molecular pathway as a Robbins fact.
Slide 43 · Geography modifies the observed phenotype
India
Noncirrhotic portal fibrosis/hypertension has been particularly common; Incidence appears to be declining.
East Asia, particularly Japan
Female predominance is described; Splenomegaly and rheumatologic associations are emphasized.
Slide 44 · India: Bleeding as a presentation
An important burden of noncirrhotic portal fibrosis and hypertension in India.
The incidence appears to be declining account.
Upper gastrointestinal bleeding is a prominent presentation.
The clinical event reflects portal hypertension rather than a requisite diagnosis of cirrhosis.
Slide 45 · Japan: Splenomegaly-centered presentation
East Asian cases, especially those described from Japan, show a female predominance.
Splenomegaly is a characteristic presenting feature in this account.
Rheumatologic diseases may coexist.
These are geographical patterns, not exclusive diagnostic criteria.
Slide 46 · HIV-associated small-branch disease
Untreated HIV
Noncirrhotic portal hypertension in patients without HIV treatment.
Antiretroviral-treated HIV
Cases during antiretroviral therapy are also reported and may represent a treatment complication.
Slide 47 · Do not infer a single HIV mechanism
HIV clinical context
Small-branch portal vascular disease
Noncirrhotic portal hypertension
Variceal / congestive sequelae
Causality of infection versus treatment is not settled in the supplied excerpt.
Slide 48 · Contrasting small-branch phenotypes
Setting
Noted association
Frequent presentation in source
India
Noncirrhotic portal fibrosis
Upper gastrointestinal bleeding
East Asia / Japan
Female predominance; rheumatologic disease
Splenomegaly
HIV settings
Untreated infection or antiviral therapy
Portal hypertensive disease (variable)
Slide 49 · Bleeding is a vascular endpoint
Resistance within portal circulation
Portosystemic venous collaterals
Distended esophageal varices
Potentially serious hemorrhage
Variceal rupture is a clinically important consequence in the core source.
Slide 50 · Splenomegaly reflects portal-system congestion
The source figure associates impaired portal inflow with splenomegaly.
Congestion affects structures draining into the portal venous system.
Splenomegaly also features prominently in the East Asian noncirrhotic portal hypertensive phenotype.
It is a consequence or clue, not proof of a particular etiology.
Slide 51 · Intestinal congestion in portal inflow obstruction
Anatomic basis
Splanchnic bowel venous drainage feeds the portal circulation.
Clinicopathologic implication
Impaired outflow can cause intestinal congestion; Severity depends on the location and degree of vascular involvement.
Slide 52 · Ascites must be interpreted in context
Delayed ascites may accompany extrahepatic portal obstruction following neonatal injury.
Ascites also occurs in other categories of hepatic circulatory disease.
A finding of ascites alone does not locate the obstruction to the portal vein.
Combine ascites with varices, splenomegaly, pain and the likely vascular level.
Slide 53 · The severe end of the clinical spectrum
Incidental / delayed
Subclinical history possible.
Chronic portal hypertension
Varices and upper GI bleeding may dominate.
Severe acute obstruction
Textbook warns that some events are potentially lethal.
Slide 54 · Why transplantation enters the discussion
Liver transplantation can be necessary in selected noncirrhotic portal hypertensive disorders.
The purpose in the stated context is avoidance of fatal sequelae of portal hypertension.
It should not be taught as universal therapy for every portal-vein thrombosis.
The source provides no patient-selection algorithm or management protocol.
Slide 55 · Portal versus hepatic venous obstruction
Feature
Portal-vein obstruction
Hepatic vein thrombosis
Primary site
Portal inflow
Major hepatic venous outflow
Important findings
Varices; splenomegaly; bowel congestion
Hepatomegaly; pain; ascites
Textbook term
Portal vein obstruction / thrombosis
Budd–Chiari syndrome
Slide 56 · A broader differential: Pre-, intra-, posthepatic
Level
Examples in Robbins
Prehepatic
Portal vein thrombosis; portal-vein narrowing
Intrahepatic
Cirrhosis; schistosomiasis; nodular regenerative hyperplasia
Posthepatic
Hepatic venous outflow disease; right heart failure
Slide 57 · Hepatic artery compromise is a different lesion
Portal venous obstruction
Impedes venous blood delivery from splanchnic drainage, often producing portal hypertension.
Hepatic arterial obstruction
Can produce focal ischemic liver infarction, especially when compensating blood supplies fail.
Slide 58 · Localize first, then explain the cause
Find portal hypertensive manifestations
Determine likely obstruction level
Identify local and systemic associations
Integrate into pathologic mechanism
Educational reasoning sequence distilled from the Robbins anatomical framework.
Slide 59 · Illustrative vignette: Delayed presentation
Illustrative teaching vignette
A child develops upper gastrointestinal variceal bleeding. Neonatal history includes umbilical sepsis and an umbilical venous catheter.
Which pathophysiologic link best connects the history to the presentation?
Prior subclinical extrahepatic portal occlusion is plausible.
Years later, portal hypertension creates esophageal varices.
The history is suggestive, not a stand-alone confirmatory test.
Slide 60 · Illustrative vignette: Abdominal infection
Illustrative teaching vignette
A patient with acute diverticulitis develops an occlusive process in the portal venous drainage territory.
Which route and term should be considered?
Infection can produce septic thrombophlebitis of the splanchnic venous circulation.
Portal involvement is termed pylephlebitis.
The initiating disorder is in the abdominal venous drainage field.
Slide 61 · Illustrative vignette: Hematologic disease
Illustrative teaching vignette
An adult with a known myeloproliferative neoplasm develops portal vein thrombosis.
What is the etiologic mechanism emphasized?
Myeloproliferative disease predisposes to thrombosis.
Polycythemia vera and platelet abnormalities are specifically noted.
Consider systemic prothrombotic context, not just a local portal lesion.
Slide 62 · Illustrative vignette: Parasitic portal disease
Illustrative teaching vignette
Portal hypertension occurs without established cirrhosis; Small portal branches contain parasite eggs with granulomatous inflammation.
How does this finding cause portal hypertension?
This is the textbook lesion of schistosomiasis.
Eggs plus granulomatous response obstruct the smallest portal branches.
Microvascular resistance can produce noncirrhotic portal hypertension.
Slide 63 · Illustrative vignette: Regional phenotype
Illustrative teaching vignette
A woman in Japan has splenomegaly, portal hypertension and a coexisting rheumatologic disorder, without an established cirrhotic diagnosis.
Which Robbins disease grouping fits this presentation?
Idiopathic noncirrhotic portal hypertension is an appropriate category to consider.
The East Asian/Japanese phenotype includes female predominance and splenomegaly.
The association does not identify a single proven mechanism.
Slide 64 · Integrating the three vascular levels
Obstruction level
Typical source context
Dominant conceptual lesson
Extrahepatic trunk
Infection; thrombophilia; trauma; pancreatitis; tumor
Etiologically heterogeneous large-vessel occlusion
Intrahepatic radicles
Acute thrombosis; malignancy; hypercoagulability
Intrahepatic portal inflow blockage
Small portal branches
Schistosomiasis; heterogeneous noncirrhotic PH
Microvascular disease without requisite cirrhosis
Slide 65 · Five clinically consequential distinctions
Portal inflow obstruction is not the same process as hepatic venous outflow obstruction.
Variceal bleeding can follow a silent extrahepatic event from years earlier.
HCC vascular invasion and venous thrombus are different etiologic mechanisms.
Small portal branch obstruction can produce portal hypertension without cirrhosis.
Associations in idiopathic noncirrhotic portal hypertension are not established causation.
Slide 66 · Source references and scope
Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th ed. (2026). Section: “Portal Vein Obstruction and Thrombosis.”
Related source sections: “Portal Hypertension” and “Circulatory Disorders” — contextual anatomy and comparisons.
Related source section: “Esophageal Varices” — mechanism of portal-systemic collateralization.
Conceptual diagrams and educational vignettes are original, editable teaching constructions; no patient images or textbook figure facsimiles are used.